- Home
- UNCY vs PYN Comparison
UNCY vs PYN Comparison
Compare UNCY & PYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- PYN
- Stock Information
- Founded
- UNCY 2016
- PYN 2002
- Country
- UNCY United States
- PYN United States
- Employees
- UNCY N/A
- PYN N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- PYN Investment Managers
- Sector
- UNCY Health Care
- PYN Finance
- Exchange
- UNCY Nasdaq
- PYN Nasdaq
- Market Cap
- UNCY 31.9M
- PYN 34.6M
- IPO Year
- UNCY 2021
- PYN N/A
- Fundamental
- Price
- UNCY $0.46
- PYN $6.04
- Analyst Decision
- UNCY Strong Buy
- PYN
- Analyst Count
- UNCY 4
- PYN 0
- Target Price
- UNCY $5.50
- PYN N/A
- AVG Volume (30 Days)
- UNCY 1.9M
- PYN 19.9K
- Earning Date
- UNCY 11-13-2024
- PYN 01-01-0001
- Dividend Yield
- UNCY N/A
- PYN 5.07%
- EPS Growth
- UNCY N/A
- PYN N/A
- EPS
- UNCY N/A
- PYN N/A
- Revenue
- UNCY N/A
- PYN N/A
- Revenue This Year
- UNCY N/A
- PYN N/A
- Revenue Next Year
- UNCY N/A
- PYN N/A
- P/E Ratio
- UNCY N/A
- PYN N/A
- Revenue Growth
- UNCY N/A
- PYN N/A
- 52 Week Low
- UNCY $0.20
- PYN $4.84
- 52 Week High
- UNCY $1.82
- PYN $6.60
- Technical
- Relative Strength Index (RSI)
- UNCY 48.64
- PYN 45.93
- Support Level
- UNCY $0.41
- PYN $5.97
- Resistance Level
- UNCY $0.55
- PYN $6.11
- Average True Range (ATR)
- UNCY 0.06
- PYN 0.10
- MACD
- UNCY -0.01
- PYN 0.01
- Stochastic Oscillator
- UNCY 23.47
- PYN 33.43
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.
About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest
PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.